Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era. (9th December 2022) - Qualls, David; Imber, Brandon S.; Okwali, Michelle; Hamlin, Paul A.; Kumar, Anita; Lahoud, Oscar B.; Matasar, Matthew J.; Noy, Ariela; Owens, Colette; Zelenetz, Andrew D.; North, Victoria S.; Schöder, Heiko; et al.